Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics
Yung-Jue Bang, Suayib Yalcin, Arnaud Roth, Simon Hitier, Mikhail Ter-Ovanesov, Chew-Wun Wu, John Zalcberg
Asia-Pacific Journal of Clinical Oncology | WILEY | Published : 2014
The REGATE study was sponsored by Sanofi. Editorial assistance was provided by Neil Anderson, PhD, of Adelphi Communications Ltd. Editorial support was funded by Sanofi. The authors were fully responsible for all content and editorial decisions and did not receive financial support or compensation related to the development of the manuscript. Y-JB has conducted research sponsored by AstraZeneca, GlaxoSmithKline, Green Cross, Hanmi, Merck, Novartis, Pfizer, Roche and Sanofi; has attended advisory/consultancy meetings for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Green Cross, Hanmi, Merck, Novartis, Otsuka, Pfizer, Roche and Sanofi; and has received honoraria from AstraZeneca, GlaxoSmithKline, Novartis, Pfizer and Roche. JZ has conducted research sponsored by Sanofi.